Chemoinformaics analysis of D-ALPHA-OXYGLUTARIC-ACID
| Molecular Weight | 250.338 | nRot | 2 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 14 |
| Exact Molecular Weight | 250.157 | nRing | 2 |
| Solubility: LogS | -2.91 | nHRing | 0 |
| Solubility: LogP | 1.707 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 42.1254 |
| nHD | 1 | BPOL | 23.8066 |
| QED | 0.766 |
| Synth | 4.018 |
| Natural Product Likeliness | 2.55 |
| NR-PPAR-gamma | 0.022 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.024 |
| CACO-2 | -4.868 |
| MDCK | 0.0000138 |
| BBB | 0.135 |
| PPB | 0.905057 |
| VDSS | 0.332 |
| FU | 0.0588733 |
| CYP1A2-inh | 0.039 |
| CYP1A2-sub | 0.797 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.666 |
| CYP2c9-inh | 0.119 |
| CYP2c9-sub | 0.526 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.378 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.182 |
| CL | 7.439 |
| T12 | 0.812 |
| hERG | 0.011 |
| Ames | 0.022 |
| ROA | 0.157 |
| SkinSen | 0.051 |
| Carcinogencity | 0.535 |
| EI | 0.11 |
| Respiratory | 0.849 |
| NR-Aromatase | 0.014 |
| Antiviral | Yes |
| Prediction | 0.917034 |